Activities per year
Activities
- 1 - 50 out of 101 results
Search results
-
Dutch Cancer Foundation (External organisation)
Marjolein van Egmond (Member)
1 Jan 2024 → …Activity: Membership › Membership of board › Academic
-
Academic founder and consultant
Marjolein van Egmond (Consultant)
1 Jun 2023 → …Activity: Consultancy › Academic
-
Bispecific Neutrophil Engagers for Cancer Immunotherapy
Marjolein van Egmond (Speaker)
22 Feb 2023Activity: Lecture / Presentation › Invited talk › Academic
-
Novel FcαRI Bispecific Antibody Immunocytokines for the Recruitment of Myeloid Effector Cells in Cancer Therapy
Marjolein van Egmond (Speaker)
14 Nov 2023Activity: Lecture / Presentation › Invited talk › Academic
-
Novel Bispecific Antibody Immunocytokines for the Recruitment of Myeloid Effector Cells in Cancer Therapy
Marjolein van Egmond (Speaker)
21 Jun 2023Activity: Lecture / Presentation › Invited talk › Academic
-
Neutrophils and cancer immunotherapy
Marjolein van Egmond (Speaker)
22 Nov 2023Activity: Lecture / Presentation › Invited talk › Academic
-
JJP Biologics (External organisation)
Marjolein van Egmond (Chair)
1 Jan 2022 → …Activity: Membership › Membership of board › Academic
-
ZonMw - The Netherlands Organisation for Health Research and Development (External organisation)
Marjolein van Egmond (Member)
1 Apr 2022 → …Activity: Membership › Membership of committee › Academic
-
Webinar Covid19 vaccines
Marjolein van Egmond (Speaker)
8 Nov 2022Activity: Lecture / Presentation › Invited talk › Academic
-
ESES/UEMS examination endocrine surgery 2022
Els J. M. Nieveen van Dijkum (Examiner)
25 May 2022Activity: PhD thesis Examination › Examination › Educational
-
ZonMw - The Netherlands Organisation for Health Research and Development (External organisation)
Marjolein van Egmond (Member)
1 Apr 2022 → …Activity: Membership › Membership of board › Academic
-
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Marjolein van Egmond (Speaker)
5 Oct 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Augmented anticancer BsAb boost neutrophil cytotoxicity.
Marjolein van Egmond (Speaker)
11 Nov 2021Activity: Lecture / Presentation › Invited talk › Academic
-
e-seminar ‘Covid-19 vaccines'
Marjolein van Egmond (Speaker)
7 Jan 2021Activity: Lecture / Presentation › Invited talk › Academic
-
ZonMw - The Netherlands Organisation for Health Research and Development (External organisation)
Marjolein van Egmond (Member)
1 Sept 2021 → …Activity: Membership › Membership of committee › Academic
-
KWF Kanker bestrijding (External organisation)
Marjolein van Egmond (Member)
1 Jun 2021 → …Activity: Membership › Membership of committee › Academic
-
Het afweersysteem; Werking van vaccins
Marjolein van Egmond (Speaker)
14 Jan 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Dutch Cancer Foundation (External organisation)
Marjolein van Egmond (Member)
1 Jun 2021 → 1 Jan 2024Activity: Membership › Membership of board › Academic
-
Augmented anticancer BsAb boost neutrophil cytotoxicity.
Marjolein van Egmond (Speaker)
4 Nov 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona
Marjolein van Egmond (Speaker)
2 Feb 2021Activity: Lecture / Presentation › Invited talk › Academic
-
IgA and neutrophil FcαRI: the past, present and future.
Marjolein van Egmond (Speaker)
26 Mar 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Openingspitch COVID-19 vaccines
Marjolein van Egmond (Speaker)
26 May 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Een prik; waarom zou ik
Marjolein van Egmond (Speaker)
17 Jan 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Het afweersysteem en vaccins; Een korte uitleg in tijden van Corona
Marjolein van Egmond (Speaker)
14 Apr 2021Activity: Lecture / Presentation › Invited talk › Academic
-
Bohn Stafleu van Loghum (External organisation)
Marjolein van Egmond (Member)
1 Sept 2021 → …Activity: Membership › Membership of board › Academic
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
2 Nov 2020 → 4 Nov 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
24 Aug 2020 → 27 Aug 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
7 Feb 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
2 Feb 2020 → 7 Feb 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Speaker)
12 Nov 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Speaker)
9 Jan 2020Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Keynote speaker)
10 Dec 2019Activity: Lecture / Presentation › Invited talk › Academic
-
CCA - Cancer biology and immunology (Organisational unit)
Marjolein van Egmond (Member)
1 Jan 2019 → …Activity: Membership › Membership of committee › Academic
-
-
IgA in autoimmunity and in therapy.
Marjolein van Egmond (Invited speaker)
17 Jun 2019Activity: Lecture / Presentation › Invited talk › Academic
-
Immunoglobulin A: Trojan horse or magic bullet?
Marjolein van Egmond (Invited speaker)
27 Aug 2019Activity: Lecture / Presentation › Invited talk › Academic
-
French National Research Agency (ANR) (External organisation)
Marjolein van Egmond (Member)
1 Jan 2019 → 31 Dec 2019Activity: Membership › Membership of committee › Academic
-
‘Targeting of the IgA Fc receptor in disease’.
Marjolein van Egmond (Invited speaker)
26 Jun 2019Activity: Lecture / Presentation › Invited talk › Academic
-
Cancers (Journal)
Els J. M. Nieveen van Dijkum (Reviewer)
2019 → 2022Activity: Peer review and Editorial work › Publication peer-review
-
IgA as anti-cancer therapeutic antibodies 2.0?
Marjolein van Egmond (Invited speaker)
21 May 2019Activity: Lecture / Presentation › Invited talk › Academic
-
AI&II retreat
Marjolein van Egmond (Participant)
6 Jun 2019Activity: Participating in or organising an event › Organising a conference, workshop, ... › Academic
-
5th European Congress of Immunology
M van Egmond (Organiser)
2018Activity: Participating in or organising an event › Organising a conference, workshop, ... › Academic
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
14 Sept 2018Activity: Lecture / Presentation › Invited talk › Academic
-
‘Translating antibody – effector cell cross-talk to immunotherapy’.
Marjolein van Egmond (Invited speaker)
25 Feb 2018 → 2 Mar 2018Activity: Lecture / Presentation › Invited talk › Academic
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
M van Egmond (Invited speaker)
Jun 2018Activity: Lecture / Presentation › Invited talk › Academic
-
thesis committee •J.P. Veluchamy
M van Egmond (Examiner)
2018Activity: PhD thesis Examination › Examination › Educational
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
11 Sept 2018Activity: Lecture / Presentation › Invited talk › Academic
-
‘Immunoglobulin A: Trojan horse or magic bullet?’
Marjolein van Egmond (Invited speaker)
12 Sept 2018Activity: Lecture / Presentation › Invited talk › Academic
-
‘Translating antibody – effector cell cross-talk to immunotherapy’.
Marjolein van Egmond (Invited speaker)
17 Apr 2018 → 18 Apr 2018Activity: Lecture / Presentation › Invited talk › Academic
-
Keystone Symposium ‘Antibodies as Drugs: Translating Molecules into Treatments’, (Event)
M van Egmond (Member)
2018Activity: Membership › Membership of committee › Academic